FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

VV Lyskovtsev

Research Profile

Chemicals & Drugs

Living Beings

Procedures

Disorders

Physiology

Coronary Circulation

Concepts & Ideas

Co-author Network

Publications

TOP 3
NV Kaverina; VV Lyskovtsev; EP Popova
[Comparative study of the electrophysiological properties of class iii medicinals (cardiocyclide, nibentan, sotalol) and evaluation of their efficacy in atrial fibrillation produced by auricular and vagal stimulation].
EP Popova; VV Lyskovtsev; NV Kaverina
[Effect of the class III antiarrhythmic drug nibentan in vagotonic atrial fibrillation].
NV Kaverina; VV Lyskovtsev; EP Popova
[Comparative study of electrophysiological mechanisms of anti-arrhythmia III class agents, cardiocyclide, nibentan, and sotalol during experimental myocardial infarction and sympathetic stimulation].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of VV Lyskovtsev (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: NV Kaverina; VV Lyskovtsev; EP Popova
[Comparative study of the electrophysiological properties of class iii medicinals (cardiocyclide, nibentan, sotalol) and evaluation of their efficacy in atrial fibrillation produced by auricular and vagal stimulation].
Eksperimental'naia i klinicheskaia farmakologiia 2007;70(1):11-6.
2006: EP Popova; VV Lyskovtsev; NV Kaverina
[Effect of the class III antiarrhythmic drug nibentan in vagotonic atrial fibrillation].
Eksperimental'naia i klinicheskaia farmakologiia 2006;69(1):24-7.
2003: NV Kaverina; VV Lyskovtsev; EP Popova
[Comparative study of electrophysiological mechanisms of anti-arrhythmia III class agents, cardiocyclide, nibentan, and sotalol during experimental myocardial infarction and sympathetic stimulation].
Eksperimental'naia i klinicheskaia farmakologiia 2003;66(1):27-33.
2002: NV Kaverina; VV Lyskovtsev; EP Popova
[Electrophysiological effects of ethacizine in experimental myocardial infarction and stimulation of sympathetic heart innervation].
Eksperimental'naia i klinicheskaia farmakologiia 2002;65(6):23-7.
2001: NV Kaverina; VV Lyskovtsev; E P Kishchuk
[Effect of the novel III class anti-arrhythmia preparation (AL-275) in experimental myocardium and sympathetic stimulation].
Eksperimental'naia i klinicheskaia farmakologiia 2001;64(1):33-7.
1999: H Poppe; R Schindler; W Sauer; Degenhard Marx; R Bartsch; NV Kaverina; A M Lichoscherstow; S F Sokolov; VV Lyskovtsev; S B Seredenin; S A Borisenko
New aminocarboxamides with class III anti-arrhythmic activity.
Archiv der Pharmazie 1999;332(7):233-42.
1998: NV Kaverina; GG Chichkanov; E M Bugriĭ; MB Vititnova; E A Tolmacheva; AI Turilova; S A Kryzhanovskiĭ; VV Lyskovtsev; A P Rodionov; V L Beloborodov
[The pharmacology of the new combined anti-arrhythmia preparation metatsizin].
Eksperimental'naia i klinicheskaia farmakologiia 1998;61(2):33-6.
1998: NV Kaverina; VV Lyskovtsev; S F Sokolov; H Poppe; Degenhard Marx; E P Kishchuk; AI Turilova; AM Likhosherstov; IB Tsorin; GG Chichkanov
[A new class-III antiarrhythmic preparation among the dicyclohexylamides of aminocarboxylic acids].
Vestnik Rossiĭskoĭ akademii meditsinskikh nauk / Rossiĭskaia akademiia meditsinskikh nauk 1998;(11):42-6.
1990: A P Rodionov; N N Zolotov; VV Lyskovtsev; K Iu Zalilov; H Poppe
[The relationship between the physicochemical and pharmacokinetic parameters and the anti-arrhythmia activity of bonnecor and its metabolites].
Farmakologiia i toksikologiia 1990;53(3):50-1.
1990: GG Chichkanov; E A Tolmacheva; VV Lyskovtsev; E K Grigor'eva; D D Matsievskiĭ
[The effect of bonnecor on cardiac hemodynamics, blood supply and function in experimental myocardial ischemia].
Farmakologiia i toksikologiia 1990;53(3):38-40.
1990: S Iu Berdiaev; VV Lyskovtsev; Z P Senova; N V Darinskiĭ; E K Grigor'eva; E A Tolmacheva; AI Turilova; A N Gritsenko; NV Kaverina
[Bonnecor--a new anti-arrhythmia preparation].
Farmakologiia i toksikologiia 1990;53(3):33-6.
1990: A N Gritsenko; VV Lyskovtsev; Z P Senova; A P Skoldinov; A Stark; G Wunderlich; H Poppe; R Barch
[The relationship between the chemical structure and anti-arrhythmia action of a number of omega-aminoacyl-3-carbalcoxyaminodibenzazepines].
Farmakologiia i toksikologiia 1990;53(3):30-2.
1990: M I Mironova; VV Lyskovtsev; NV Kaverina
[A first trial in the clinical study of bonnecor].
Farmakologiia i toksikologiia 1990;53(3):65-7.
1990: A P Rodionov; VV Lyskovtsev; N A Ignatova; E A Tolmacheva; E K Grigor'eva; G F Belinskiaia; B V Sheĭnberg
[A comparative study of the pharmacokinetics and pharmacodynamics of bonnecor].
Farmakologiia i toksikologiia 1990;53(3):40-3.
1988: D D Matsievskiĭ; VV Lyskovtsev; E K Grigor'eva; E A Zbrizher; GG Chichkanov
[Quantitative assessment of the blood supply to the focus of myocardial ischemia in dogs in pharmacological research].
Biulleten' eksperimental'noĭ biologii i meditsiny 1988;106(11):531-3.
1986: Z P Senova; VV Lyskovtsev; E K Grigor'eva; V V Gorbunova; NV Kaverina
[Anti-arrhythmia and antifibrillatory properties of dibenzazepine derivatives].
Kardiologiia 1986;26(8):24-8.
1985: NV Kaverina; A P Skoldinov; Z P Senova; A N Gritsenko; VV Lyskovtsev
[Pharmacology of ethacizin].
Farmakologiia i toksikologiia 1985;48(5):43-9.
1984: NV Kaverina; VV Lyskovtsev; Z P Senova; E K Grigor'eva
[Ethacizin: pharmacologic properties and prospects for clinical application].
Kardiologiia 1984;24(5):52-7.